Drug safely cuts prostate cancer risk, study finds (Associated Press, 14 August 2013)

15 Aug 2013


An 18 year follow-up study from the US, published in New England Journal of Medicine, assesses prostate cancer incidence and mortality rates when using finasteride as a preventative medicine vs placebo.

Full article


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story